ATE322260T1 - Nateglinide zubereitung in tablettenform - Google Patents

Nateglinide zubereitung in tablettenform

Info

Publication number
ATE322260T1
ATE322260T1 AT97912459T AT97912459T ATE322260T1 AT E322260 T1 ATE322260 T1 AT E322260T1 AT 97912459 T AT97912459 T AT 97912459T AT 97912459 T AT97912459 T AT 97912459T AT E322260 T1 ATE322260 T1 AT E322260T1
Authority
AT
Austria
Prior art keywords
tablet form
meals
carboxymethyl cellulose
tablet composition
nateglinide preparation
Prior art date
Application number
AT97912459T
Other languages
English (en)
Inventor
Akira Yabuki
Kawasaki-Ku
Masato Kaida
Takahiko Ando
Nobutaka Ninomiya
Masanao Ozaki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18100283&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE322260(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of ATE322260T1 publication Critical patent/ATE322260T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
AT97912459T 1996-11-15 1997-11-14 Nateglinide zubereitung in tablettenform ATE322260T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31854196 1996-11-15

Publications (1)

Publication Number Publication Date
ATE322260T1 true ATE322260T1 (de) 2006-04-15

Family

ID=18100283

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05014497T ATE503472T1 (de) 1996-11-15 1997-11-14 Nateglinide-tablettenzubereitungen
AT97912459T ATE322260T1 (de) 1996-11-15 1997-11-14 Nateglinide zubereitung in tablettenform

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05014497T ATE503472T1 (de) 1996-11-15 1997-11-14 Nateglinide-tablettenzubereitungen

Country Status (14)

Country Link
US (4) US6143323A (de)
EP (3) EP0965339B1 (de)
JP (1) JP4171091B2 (de)
KR (1) KR100343062B1 (de)
CN (1) CN1245158C (de)
AT (2) ATE503472T1 (de)
AU (1) AU718350B2 (de)
CA (1) CA2271865C (de)
DE (2) DE69740161D1 (de)
DK (1) DK1586314T3 (de)
ES (2) ES2257772T3 (de)
PT (2) PT965339E (de)
TW (1) TW492878B (de)
WO (1) WO1998022105A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2257772T3 (es) 1996-11-15 2006-08-01 Ajinomoto Co., Inc. Preparacion de nateglinida en comprimidos.
PT1121103E (pt) 1998-05-18 2007-02-28 Takeda Pharmaceutical Comprimidos de desintegração oral compreendendo um benzimidazole
ATE481090T1 (de) 1998-07-28 2010-10-15 Takeda Pharmaceutical Leicht zerfallende feste zubereitung
JP2000119160A (ja) * 1998-10-06 2000-04-25 Kanebo Ltd 皮膚化粧料
CO5200844A1 (es) * 1999-09-17 2002-09-27 Novartis Ag Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
US6559188B1 (en) 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
US6878749B2 (en) 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
RU2002120498A (ru) 1999-12-28 2004-04-10 Адзиномото Ко., Инк. (Jp) Противодиабетический препарат для перорального введения
PL357719A1 (en) * 2000-03-17 2004-07-26 Ajinomoto Co, Inc. Drugs for complications of diabetes and neuropathy and utilization thereof
CA2425538C (en) * 2000-10-18 2010-10-12 Ajinomoto Co., Inc. Methods for producing nateglinide crystals
ES2290173T3 (es) 2000-10-18 2008-02-16 Ajinomoto Co., Inc. Procedimiento para la preparacion de acilfenilalaninas.
ATE429217T1 (de) * 2000-10-24 2009-05-15 Ajinomoto Kk Nateglinid enthaltende hydrophile arzneimittelpräparate
MXPA03003575A (es) * 2000-10-24 2003-07-14 Ajinomoto Kk Procedimiento para elaborar la forma b del cristal de nateglinida.
ES2307653T3 (es) * 2000-10-24 2008-12-01 Ajinomoto Co., Inc. Preparaciones que contienen nateglinida.
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
JP2003252749A (ja) * 2002-03-04 2003-09-10 Shin Etsu Chem Co Ltd 外用基剤
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
CN1247194C (zh) * 2002-08-27 2006-03-29 石药集团中奇制药技术（石家庄）有限公司 一种那格列奈包合物
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
KR20080083071A (ko) 2003-08-08 2008-09-12 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005016315A1 (en) * 2003-08-14 2005-02-24 Ranbaxy Laboratories Limited Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler
KR20120064735A (ko) * 2004-04-01 2012-06-19 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005117840A1 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising pulverized granules of nateglinide of form b
WO2006013444A1 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
EP1802286B1 (de) * 2004-08-04 2008-07-23 ALZA Corporation Zusammensetzung mit verzögerter arzneimittelfreisetzung mit einem aufsteigenden nullordnung-freigabe-muster; verfahren zur herstellung einer solchen zusammensetzung"
KR20070058540A (ko) * 2004-10-01 2007-06-08 니폰 조키 세야쿠 가부시키가이샤 고형 의약제제
US7276198B2 (en) * 2004-12-28 2007-10-02 The Goodyear Tire & Rubber Company Method and mold for making tire with tie bar
EP1891971A4 (de) * 2005-01-31 2010-02-03 Ajinomoto Kk Medizinische zusammensetzung mit hyperglykämiemittel zur linderung oder behandlung von glucose-intoleranz, borderline-diabetes, insulinresistenz und hyperinsulinämie
EP2100610A4 (de) * 2006-12-07 2009-12-02 Daiichi Sankyo Co Ltd Pharmazeutische zusammensetzung mit niedrig substituierter hydroxypropylcellulose
WO2008072533A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 固形製剤の製造方法
WO2008072532A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 貯蔵安定性が改善された医薬組成物
TWI428151B (zh) * 2006-12-07 2014-03-01 Daiichi Sankyo Co Ltd 含有甘露醇或乳糖之固形製劑
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
DK0526171T3 (da) 1991-07-30 1997-08-25 Ajinomoto Kk Krystaller af N-(trans-4-isopropylcyclohexylcarbonyl)-Dphenylalanin og fremgangsmåder til fremstilling deraf
WO1993010775A1 (en) * 1991-11-26 1993-06-10 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
ES2257772T3 (es) * 1996-11-15 2006-08-01 Ajinomoto Co., Inc. Preparacion de nateglinida en comprimidos.

Also Published As

Publication number Publication date
DE69740161D1 (de) 2011-05-12
EP0965339B1 (de) 2006-04-05
EP2277517A1 (de) 2011-01-26
CA2271865C (en) 2003-10-14
US6844008B2 (en) 2005-01-18
DK1586314T3 (da) 2011-06-20
KR20000053312A (ko) 2000-08-25
US20020028239A1 (en) 2002-03-07
CN1242704A (zh) 2000-01-26
EP0965339A4 (de) 2003-04-23
PT965339E (pt) 2006-06-30
KR100343062B1 (ko) 2002-07-02
AU4965497A (en) 1998-06-10
EP1586314A1 (de) 2005-10-19
US20030147951A1 (en) 2003-08-07
CN1245158C (zh) 2006-03-15
EP1586314B1 (de) 2011-03-30
US6296872B1 (en) 2001-10-02
PT1586314E (pt) 2011-07-01
TW492878B (en) 2002-07-01
ES2257772T3 (es) 2006-08-01
JP4171091B2 (ja) 2008-10-22
AU718350B2 (en) 2000-04-13
ES2364145T3 (es) 2011-08-25
DE69735644T2 (de) 2007-05-03
JPH10194969A (ja) 1998-07-28
EP0965339A1 (de) 1999-12-22
WO1998022105A1 (fr) 1998-05-28
ATE503472T1 (de) 2011-04-15
DE69735644D1 (de) 2006-05-18
CA2271865A1 (en) 1998-05-28
US6641841B2 (en) 2003-11-04
US6143323A (en) 2000-11-07

Similar Documents

Publication Publication Date Title
ATE322260T1 (de) Nateglinide zubereitung in tablettenform
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
DK420385A (da) Antioestrogent laegemiddel til perkutan indgift
MY118164A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
ES2123903T3 (es) Composicion nutritiva conteniendo fibra.
KR880010764A (ko) 과콜레스테롤혈중 치료용 혼합물
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
BR0016801A (pt) Preparação antidiabética para administração oral
TW533077B (en) Agent for improving the blood circulation
MX9100246A (es) Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion
CO5160272A1 (es) Combinacion de cerivastatina y fibratos
IS2234B (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
EP1108429A3 (de) Verbesserte Aminosäurenzusammensetzung zum Bereitstellen von Aminosäurenergänzungen oder Eiweissersatz, insbesondere zur Behandlung und/oder Verwaltung von bestimmten Erkrankungen
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
CN1109357A (zh) 一种美容保健制品及工艺方法
JPS54148090A (en) Peroral cholesterol-depressant
JPS57139013A (en) Prophylactic or remedy for periodontosis
CA1179267A (en) Composition for relieving toothache pain
RU2053782C1 (ru) Способ лечения язвенно-некротического стоматита
KR970058708A (ko) 엘-무스콘(l-muscone)의 의약용도
ES283591Y (es) Una tableta de dosificacion farmaceutica adecuada para administracion oral
RU94030887A (ru) N-ацетил-дегидрофенилаланил-l-метионин
KR910015294A (ko) 약제 조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties